Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
| Image |  |
|---|---|
| Description | scientific article published on 27 November 2017 |
| Author/s |
author: Layla J Barkal Benyamin Rosental Roy L Maute Robin Z Cheng Jonathan M Tsai Irving Weissman |
| Publication date | November 27, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |